Evotec SE (EVO) Cash from Financing Activities (2009 - 2026)

Evotec SE (EVO) reported Cash from Financing Activities of -$22349.5 for Q1 2026, down 159.97% on a YoY basis from $37267.2 in Q1 2025, and up 99.95% sequentially from -$43.8 million in Q4 2025.

Evotec SE (EVO) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Evotec SE (EVO) has 9 years of Cash from Financing Activities data on file, last reported at -$22349.5 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 159.97% year-over-year to -$22349.5; the trailing twelve-month figure through Mar 2026 stood at -$43.9 million (up 74.56% YoY), and the FY2025 full-year result was -$43.8 million, up 74.61% from the prior year.
  • Cash from Financing Activities rose to -$22349.5 in Q1 2026, from -$43.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $77.4 million in Q4 2023 to a low of -$172.4 million in Q4 2024.
  • A 5-year average of -$11.7 million and a median of -$7889.6 in 2024 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 991.27% in 2023 and slumped 1780.81% in 2024, its largest moves.
  • Tracing EVO's Cash from Financing Activities over 5 years: stood at -$59.3 million in 2022, then soared by 230.55% to $77.4 million in 2023, then sank by 322.75% to -$172.4 million in 2024, then jumped by 74.58% to -$43.8 million in 2025, then surged by 99.95% to -$22349.5 in 2026.
  • Business Quant data shows EVO's Cash from Financing Activities at -$22349.5 in Q1 2026, -$43.8 million in Q4 2025, and -$14185.3 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn - -22,349.53

Historic Data

Download Data
DateValue
Mar 31, 2026 -22,349.53
Mar 31, 2026 -22,349.53
Dec 31, 2025 -43.81 Mn
Dec 31, 2025 -43.81 Mn
Sep 30, 2025 -14,185.31
Sep 30, 2025 -14,185.31
Jun 30, 2025 -16,635.28
Jun 30, 2025 -16,635.28
Mar 31, 2025 37,267.21
Mar 31, 2025 37,267.21
Dec 31, 2024 -172.35 Mn
Dec 31, 2024 -172.35 Mn
Sep 30, 2024 -7,889.61
Sep 30, 2024 -7,889.61
Jun 30, 2024 -128,192.70
Jun 30, 2024 -128,192.70
Mar 31, 2024 -6,378.03
Mar 31, 2024 -6,378.03
Dec 31, 2023 77.38 Mn
Dec 31, 2023 77.38 Mn